LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Globe Scientific Introduces New Enhanced & Portable Clinical Centrifuges

By LabMedica International staff writers
Posted on 03 Aug 2022
Print article
Image: GCC-P portable clinical centrifuge is designed for easy transport (Photo courtesy of Globe Scientific)
Image: GCC-P portable clinical centrifuge is designed for easy transport (Photo courtesy of Globe Scientific)

Globe Scientific, Inc. (Mahwah, NJ, USA) has introduced two new centrifuges to expand on its successful range of benchtop laboratory equipment. The expansion adds a new GCC-P portable clinical centrifuge as well as a new GCC-E50 which allows for spins of 50mL centrifuge tubes at an economical cost.

The GCC-P portable clinical centrifuge is designed for easy transport to facilitate convenient field separations using the included 12VDC car power adapter. It is compact in size and packed with the features required for routine clinical applications. The included six-position rotor accommodates 1.5mL to 5mL, 7mL, 10mL and 15mL tubes (all adapters are included). A weighted base ensures the unit remains stable in field environments. An easy-to-read LCD display shows both time and speed or RCF. Two program buttons enable simple programming and recall of regularly used methods. The timer will not count down until the set speed is reached to ensure your separations and experiments work as intended. Safety is maintained by an automatic lid lock that only disengages when the program is completed or manually once the unit has completely stopped.

Globe Scientific’s GCC-E50 enhanced clinical centrifuge is an economical solution for 15mL and 50mL separations with an enhanced user interface, easy to read backlit LCD display, tight accuracy, and automated self-diagnostics on startup. An extension based on the company’s GCC-E enhanced clinical centrifuge, the GCC-E50 employs a new rotor for spinning up to six 50mL centrifuge tubes or six 15mL centrifuge tubes.

Related Links:
Globe Scientific, Inc. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more